What is it about?
This systematic review examines the barriers to conducting clinical trials in developing countries.
Featured Image
Why is it important?
Since the majority of people in the world live in these countries, it should follow that the majority of clinical trials address the problems that they experience. Of course the opposite is the case. Should a trial be conducted in a developing country, it is important to know what the barriers to successful conduct are so they can be addressed prospectively.
Perspectives
This is really important work in terms of developing high quality, equitable health care in the two thirds world.
Geoffrey Mitchell
University of Queensland
Read the Original
This page is a summary of: Barriers for conducting clinical trials in developing countries- a systematic review, International Journal for Equity in Health, March 2018, Springer Science + Business Media,
DOI: 10.1186/s12939-018-0748-6.
You can read the full text:
Contributors
The following have contributed to this page
